Splenic lymphoma: ferrite-enhanced MR imaging in rats

Area of Science:

• Biomedical Imaging
• Oncology
• Radiology

Background:

• Splenic lymphoma diagnosis can be challenging with conventional imaging.
• Novel contrast agents are needed to improve diagnostic accuracy.
• Magnetic resonance (MR) imaging offers potential for non-invasive spleen evaluation.

Purpose of the Study:

• To evaluate ferrite as a novel magnetic resonance (MR) contrast agent for detecting and diagnosing splenic lymphoma.
• To assess the ability of ferrite-enhanced MR imaging to differentiate between normal spleen, lymphomatous spleen, and benign splenomegaly.

Main Methods:

• In vitro and in vivo experiments were conducted using animal models.
• Normal rat spleens and spleens with induced diffuse and micronodular lymphoma were studied.
• MR imaging was performed before and after ferrite administration (50 mumol Fe/kg).
• T2 relaxation times and signal-to-noise ratios (S/N) were measured and compared.

Main Results:

• Before ferrite, normal and lymphomatous spleens showed similar MR characteristics.
• After ferrite administration, lymphomatous spleen exhibited significantly prolonged T2 times (27.0 msec) compared to normal spleen (10.7 msec).
• Ferrite-enhanced MR imaging revealed significantly higher S/N ratios for lymphomatous spleen (12.4) versus normal spleen (5.7).
• Ferrite-enhanced MR imaging successfully distinguished micronodular lymphoma from normal spleen.
• Benign splenomegaly due to erythroid hyperplasia showed MR characteristics indistinguishable from normal spleen after ferrite administration.

Conclusions:

• Ferrite is a promising MR contrast agent for the detection and diagnosis of splenic lymphoma.
• Ferrite-enhanced MR imaging can effectively differentiate splenic lymphoma from normal spleen.
• This technique shows potential for distinguishing malignant splenic lesions from benign conditions.